Semaglutide vs Tirzepatide: Which GLP-1 Peptide Works Better?

Semaglutide and tirzepatide are the two dominant weight loss peptides, both GLP-1 based but with a critical difference — tirzepatide adds GIP receptor activation. Clinical trial data allows a direct comparison of efficacy, side effects, and value.

Semaglutide

Tirzepatide

Mechanism

Single GLP-1 receptor agonist. Reduces appetite, slows gastric emptying, enhances insulin secretion.

Dual GIP + GLP-1 receptor agonist. Same GLP-1 effects plus GIP-mediated improvements in fat metabolism and insulin sensitivity.

Weight Loss

STEP trials: 14.9% average weight loss over 68 weeks at 2.4mg/week dose.

SURMOUNT-1: 22.5% average weight loss over 72 weeks at 15mg/week dose.

Blood Sugar Control

HbA1c reduction of 1.5-1.8% in diabetes trials. Effective for Type 2 diabetes.

HbA1c reduction up to 2.4% in SURPASS trials. Superior to semaglutide in head-to-head comparison.

Side Effects

Nausea (44%), diarrhea (30%), vomiting (24%). GI side effects diminish over time with titration.

Similar GI side effects but may have less nausea. More injection site reactions. Overall similar tolerability.

FDA Approvals

Ozempic (diabetes), Wegovy (weight loss), Rybelsus (oral diabetes).

Mounjaro (diabetes), Zepbound (weight loss).

Price Range

Research: $50-$150/vial. Rx: ~$1,300/month (Wegovy).

Research: $60-$150/vial. Rx: ~$1,000/month (Zepbound).

The Verdict

Tirzepatide produces greater weight loss and HbA1c reduction in clinical trials thanks to its dual GIP/GLP-1 mechanism. However, semaglutide has more long-term safety data, cardiovascular outcome benefits (SELECT trial), and an oral formulation option. Both are highly effective. Choice may depend on individual response, availability, and cost.

Frequently Asked Questions

Is tirzepatide better than semaglutide for weight loss?

Clinical trial data suggests yes — tirzepatide produces approximately 22% weight loss vs 15% for semaglutide at maximum doses. However, individual responses vary significantly, and semaglutide has more long-term safety data and proven cardiovascular benefits.

Can you switch from semaglutide to tirzepatide?

Switching between GLP-1 medications is common in clinical practice, though research protocols vary. A washout period may not be necessary as both target similar pathways. Dose titration should restart when switching. Consult clinical guidelines.

Which has fewer side effects?

Both have similar GI side effect profiles. Some data suggests tirzepatide may cause slightly less nausea but more injection site reactions. Both improve with dose titration. Overall tolerability is comparable.

Research & Education Only — The information on this page is for research and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any decisions.